| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/10/2013 | CN103193773A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of diseases |
| 07/10/2013 | CN103193702A Functionalization method for nitrogenous heterocyclic compound |
| 07/10/2013 | CN103193697A Light-emitting device material and light-emitting device |
| 07/10/2013 | CN102408426B Substituted aromatic urea compound and application as anticancer medicament thereof |
| 07/10/2013 | CN101910142B Modulators for beta-amyloid |
| 07/10/2013 | CN101781302B Adduct generated from phosphodiesterase inhibitor and isoflavone and application thereof |
| 07/10/2013 | CN101687841B Benzimidazole derivatives |
| 07/10/2013 | CN101652140B Enantiomeric compounds with antibacterial activity |
| 07/10/2013 | CN101558030B Condensed ring aromatic compound for organic light-emitting device and organic light-emitting device having the same |
| 07/09/2013 | USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/09/2013 | US8481740 Imidazo[1,2 a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture |
| 07/09/2013 | US8481736 Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof |
| 07/09/2013 | US8481562 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/09/2013 | US8481561 Classes of GABAA/BZR ligands |
| 07/09/2013 | US8481556 Piperidinone carboxamide azaindane CGRP receptor antagonists |
| 07/09/2013 | US8481552 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea |
| 07/09/2013 | US8481551 Gyrase and topoisomerase IV inhibitors |
| 07/09/2013 | US8481534 5- and 6-membered heterocyclic compounds |
| 07/09/2013 | US8481531 Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use |
| 07/09/2013 | CA2735932C Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 07/04/2013 | WO2013098764A1 Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof |
| 07/04/2013 | WO2013097601A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013097226A1 Fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors |
| 07/04/2013 | WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | WO2013097052A1 Bromodomain inhibitors |
| 07/04/2013 | US20130172559 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 07/04/2013 | US20130172550 P2x4 receptor antagonist |
| 07/04/2013 | US20130172549 Heteroaryl amide derivatives |
| 07/04/2013 | US20130172384 Fatty acid synthase inhibitors |
| 07/04/2013 | US20130172372 Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 07/04/2013 | US20130172366 Bridged heterocyclic compounds and methods of use |
| 07/04/2013 | US20130172365 Arylosulfonamides for the treatment of cns diseases |
| 07/04/2013 | US20130172363 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 07/04/2013 | US20130172360 Derivatives of azaindazole or diazaindazole type as medicament |
| 07/04/2013 | US20130172351 Dihydropyrazoles |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172341 Fused pyrazole derivatives as novel erk inhibitors |
| 07/04/2013 | US20130172337 Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 07/04/2013 | US20130172330 Chemokine Receptor Modulators |
| 07/04/2013 | US20130172328 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 07/04/2013 | US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 07/04/2013 | US20130172320 Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| 07/04/2013 | US20130172292 Fused heterocyclic compounds |
| 07/04/2013 | US20130171103 Methods for treating viral conditions |
| 07/04/2013 | CA2861202A1 Novel nicotinamide derivative or salt thereof |
| 07/04/2013 | CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/03/2013 | EP2610257A1 Diimidated derivative of berbamine, and preparation method therefor and use thereof |
| 07/03/2013 | EP2609097A1 Pyridyl-amine fused azadecalin modulators |
| 07/03/2013 | EP2609082A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors |
| 07/03/2013 | EP2608668A1 Fused tricyclic inhibitors of mammalian target of rapamycin |
| 07/03/2013 | CN103189377A N1/n2-lactam acetyl-coa carboxylase inhibitors |
| 07/03/2013 | CN103189376A Herbicidally active ketosultams and diketopyridines |
| 07/03/2013 | CN103189375A Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
| 07/03/2013 | CN103189374A Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
| 07/03/2013 | CN103189373A Substituted triazolopyridines |
| 07/03/2013 | CN103183678A Preparation method for nevirapine |
| 07/03/2013 | CN103183677A Application of ammonium thiosulfate as reducing agent in preparation of 5-amino-1,10-phenanthroline |
| 07/03/2013 | CN103183676A A group of 1-substituted-1, 8-naphthyridine formamide derivatives and preparation and application thereof |
| 07/03/2013 | CN103183675A Phosphodiesterase-4 inhibitor |
| 07/03/2013 | CN103183674A Fused heterocycle derivative and application thereof |
| 07/03/2013 | CN103183673A Synthesizing method of (S,S)-2,8-diazabicyclo[4.3.0]nonane |
| 07/03/2013 | CN103183672A Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof |
| 07/03/2013 | CN103183671A Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof |
| 07/03/2013 | CN102372708B Pyridyl phenanthroline compound and application |
| 07/03/2013 | CN101952259B Benzodiazepine compound and pharmaceutical composition |
| 07/03/2013 | CN101701024B Ruthenium complex, preparation method thereof and application thereof |
| 07/03/2013 | CN101679413B New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
| 07/02/2013 | USRE44338 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/02/2013 | US8476438 Process for production of camptothecin derivative |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476433 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
| 07/02/2013 | US8476294 1H-imidazo[4,5-c]quinolinone derivatives |
| 07/02/2013 | US8476292 Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods |
| 07/02/2013 | US8476290 Compound having spiro-bonded cyclic group and use thereof |
| 07/02/2013 | US8476281 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea |
| 07/02/2013 | US8476278 Thiazole Derivatives as protein kinase inhibitors |
| 07/02/2013 | US8476257 Viral polymerase inhibitors |
| 07/02/2013 | US8475686 Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound |
| 07/02/2013 | CA2716918C Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/02/2013 | CA2687608C Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 06/27/2013 | WO2013096924A1 Oligomers and polymers and polymers and methods derived from stannyl derivatives of naphthalene diimides |
| 06/27/2013 | WO2013096915A1 Stannyl derivatives of naphthalene diimides and related compositions and methods |
| 06/27/2013 | WO2013096679A1 Substituted nucleosides, nucleotides and analogs thereof |
| 06/27/2013 | WO2013096496A2 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013095761A1 Imidazopyridine derivatives as pi3 kinase inhibitors |
| 06/27/2013 | WO2013095273A1 Contrast agent for imagining myocardial perfusion |
| 06/27/2013 | WO2013093484A1 Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
| 06/27/2013 | WO2013092974A1 Quinoline derivatives as pde10a enzyme inhibitors |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013092940A1 2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/27/2013 | WO2013092791A1 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| 06/27/2013 | WO2013092739A1 [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors |
| 06/27/2013 | WO2013092467A1 7-azaindole inhibitors of crac |
| 06/27/2013 | WO2013092463A1 4-azaindole inhibitors of crac |
| 06/27/2013 | WO2013091773A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| 06/27/2013 | WO2013091279A1 Reaction products of stannyl derivatives of naphthalene diimides with rylene compounds |
| 06/27/2013 | US20130165652 Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
| 06/27/2013 | US20130165478 Pyrazolopyridinone derivatives as lpa receptor antagonists |